Best At-Home Migraine Devices for Prevention in 2026

Migraine is a neurological disease that affects more than 40 million people in the United States and more than one billion people worldwide. Preventive care can include medications, procedures, behavioral approaches, lifestyle strategies, and FDA-cleared neuromodulation devices.

At-home neuromodulation devices provide a drug-free treatment format by delivering electrical or magnetic stimulation to nerve pathways involved in migraine. These devices are not interchangeable. They differ in FDA-cleared use, age indication, prescription status, placement, treatment schedule, ownership model, refill requirements, and ongoing cost.

This guide ranks five at-home devices with preventive migraine indications. It also explains why Relivion MG, an acute-only device, is not included in the preventive ranking. Cefaly ranks first based on its combination of prescription-free access, acute and preventive programs, reusable design, support resources, and Cefaly-specific evidence. The ranking does not claim unsupported head-to-head clinical superiority.

Key Takeaways

• Cefaly ranks first for adults: It combines prescription-free U.S., Canada, and EU access, acute and preventive treatment programs, a reusable device, app-based treatment support, free coaching, and Cefaly-specific clinical evidence.
• Device formats differ: FDA-cleared neuromodulation devices vary in prescription status, age indication, treatment purpose, placement, session format, refill requirements, and ongoing cost.
• Prescription-free options are limited: Cefaly and HeadaTerm 2 are available over the counter in the United States, but only Cefaly combines acute and preventive programs in one prescription-free device.
• Pediatric indications vary: Nerivio is cleared for patients ages 8 and older, while gammaCore and SAVI Dual are cleared for patients ages 12 and older.
• Not every migraine device is preventive: Relivion MG is currently cleared in the United States for acute migraine treatment in adults, so it is not ranked as a prevention device.

Why At-Home Prevention Devices Matter

Migraine prevention is intended to reduce the frequency or burden of future attacks over time. Neuromodulation devices approach prevention without adding a medication to a person’s routine. Depending on the product, stimulation may be delivered to the trigeminal nerve, the vagus nerve, nerves in the upper arm, or the outer layers of the brain.

FDA clearance does not mean every device has the same indication or treatment schedule. A device cleared only for acute treatment should not be presented as a preventive option, and a device cleared for adults should not be presented as a pediatric treatment. Product labeling and individual clinical considerations remain important when comparing devices.

1) Cefaly

Best For: Adults seeking a prescription-free device for both acute and preventive migraine treatment

Access: No prescription required in the United States

Age Indication: Adults ages 18 and older

Starting Price: $509 one-time purchase, with replacement electrodes as the primary ongoing product cost

The Cefaly device uses external trigeminal nerve stimulation, or e-TNS, through an electrode placed on the forehead between and just above the eyebrows. Cefaly received U.S. clearance for episodic migraine prevention in 2014 and acute migraine treatment in 2017. It later became available over the counter in the United States.

Cefaly is indicated for the acute treatment of migraine with or without aura and the preventive treatment of migraine in adults ages 18 and older. It is also available without a prescription in Canada, the European Union, and other countries, although product features and support services can vary by region.

Product Features

• Two treatment programs: A 60-minute Acute program for use during a migraine attack and a 20-minute daily Prevent program for preventive treatment
• Reusable device: The device is purchased once and used with replaceable forehead electrodes rather than a monthly device subscription
• App-based support: In supported regions, the optional mobile application can control treatments, track migraine information, connect with supported health wearables, and generate reports
• Flexible intensity: Stimulation increases gradually so the user can stabilize treatment at a comfortable level
• HSA/FSA eligible: Cefaly may be purchased using eligible HSA funds
• Free coaching: Users can schedule a free session with a personal coach
• Satisfaction guarantee: If you are not satisfied with Cefaly, you can return the device for a refund within 90 calendar days of your product delivery date when purchased directly from the official website under the published refund policy

Cefaly Clinical Evidence

Cefaly’s clinical trials page summarizes more than 20 years of research, more than 12 clinical trials, and 18 peer-reviewed publications focused on Cefaly treatment.

In the randomized ACME study, 79% of participants experienced significant headache pain reduction after one hour of acute e-TNS treatment, and 63% experienced a pain decrease of at least 50%.

In the PREMICE preventive study, 38.1% of participants achieved at least a 50% reduction in monthly migraine days after three months of compliant use. The study also reported a 32.7% decrease in monthly headache days and a 36.6% decrease in acute migraine medication use.

These findings are specific to Cefaly and should not be treated as head-to-head comparisons with other devices. Individual results vary, and Cefaly treats migraine but does not cure the underlying neurological disease.

Why Cefaly Ranks First

Cefaly ranks first for adults seeking an at-home migraine device because it combines prescription-free access, acute and preventive treatment programs, a reusable ownership model, app-based treatment support, free coaching, HSA/FSA eligibility, and Cefaly-specific clinical evidence. This ranking is based on accessibility, treatment scope, product format, and patient support rather than unsupported head-to-head claims of clinical superiority.

Cefaly also has broad adoption. More than 300,000 people have chosen Cefaly, and Cefaly Connected is identified as the most frequently used neuromodulation device for migraine among patients served by Veterans Health Administration providers. Eligible veterans can review the Cefaly veterans program for access information.

2) Nerivio

Best For: Patients ages 8 and older who prefer an upper-arm device

Access: Prescription required

Age Indication: Ages 8 and older

Treatment Format: 45-minute acute or preventive sessions

Nerivio uses remote electrical neuromodulation, or REN. The device is worn on the upper arm and controlled through a smartphone application. It is indicated for acute and preventive treatment of migraine with or without aura in patients ages 8 and older.

Product Features

• Upper-arm placement: Stimulation is delivered away from the head
• Dual treatment purpose: It can be used at the onset of a migraine attack or every other day for prevention
• 45-minute sessions: Acute and preventive sessions follow the same session length
• App control: Treatment intensity and session operation are managed through the Nerivio application
• Refill structure: The current Nerivio Infinity system uses a rechargeable device with replaceable refill units, each providing 18 treatments
• Prescription access: A prescription is required, and insurance coverage or savings-program eligibility can vary

Why It Made the List

Nerivio has the broadest pediatric age indication among the preventive devices in this guide. Its upper-arm placement also provides a different format for patients who do not want a device positioned on the forehead, neck, or back of the head.

3) gammaCore

Best For: Patients researching a prescription device with migraine and additional headache indications

Access: Prescription required

Age Indication: Ages 12 and older for acute and preventive migraine treatment

Treatment Format: Handheld neck stimulation using two-minute applications

gammaCore uses non-invasive vagus nerve stimulation, or nVNS. The handheld device is positioned on the side of the neck to stimulate the vagus nerve.

Product Features

• Acute and preventive migraine use: Cleared for patients ages 12 and older
• Short applications: Each stimulation lasts two minutes
• Preventive schedule: The published migraine prevention format consists of two two-minute stimulations on the same side of the neck twice daily
• Additional indications: gammaCore also has FDA-cleared indications related to cluster headache, hemicrania continua, and paroxysmal hemicrania
• Prescription-based access: The device is supplied through a prescription and uses a refill structure based on prescribed therapy days

Why It Made the List

The short stimulation format and neck placement distinguish gammaCore from forehead, upper-arm, and magnetic-stimulation devices. Its additional headache indications may also be relevant to clinicians evaluating patients with more than one diagnosed headache disorder.

4) SAVI Dual

Best For: Patients ages 12 and older researching a magnetic rather than electrical device

Access: Prescription required

Age Indication: Ages 12 and older

Treatment Format: Single-pulse transcranial magnetic stimulation applied at the back of the head

SAVI Dual uses single-pulse transcranial magnetic stimulation, or sTMS. The device is held against the back of the head and delivers brief magnetic pulses. It is indicated for acute and preventive migraine treatment in adolescents ages 12 and older and adults.

Product Features

• Magnetic stimulation: It uses brief electromagnetic pulses rather than surface electrical stimulation
• Dual treatment purpose: It is used for both acute attacks and preventive treatment
• Brief pulse delivery: Individual pulses are delivered in less than a minute, with the number and timing based on the prescribed plan
• Smart Diary: SAVI Dual can automatically record treatment history in its cloud-based diary
• Monthly prescription model: The device is supplied through an auto-renewing monthly prescription arrangement, and the monthly fee varies with insurance coverage

Why It Made the List

SAVI Dual provides a central neuromodulation format for patients who prefer magnetic stimulation and do not want adhesive forehead electrodes. Unlike Cefaly, it requires a prescription and uses a recurring monthly access model.

5) HeadaTerm 2

Best For: Adults seeking a lower-cost, prescription-free device focused on episodic migraine prevention

Access: No prescription required in the United States

Age Indication: Adults ages 18 and older

Treatment Purpose: Preventive treatment of episodic migraine

HeadaTerm 2 is an FDA-cleared transcutaneous electrical nerve stimulation device worn on the forehead. Its U.S. indication is the prophylactic treatment of episodic migraine in adults ages 18 and older.

Product Features

• Forehead placement: Electrical stimulation is delivered through a forehead contact surface
• OTC access: No prescription is required in the United States
• Rechargeable device: The device can be recharged and reused
• Adjustable intensity: Users can select among multiple stimulation levels
• One-time purchase model: The device is sold as a direct retail purchase with replacement electrodes as the primary consumable

Why It Made the List

HeadaTerm 2 provides a prescription-free preventive option at a lower current retail price than many prescription-based systems. Its FDA-cleared U.S. indication is preventive only, so it should not be described as an FDA-cleared acute migraine device.

How to Compare At-Home Prevention Devices

Confirm the Cleared Treatment Purpose

Some devices are cleared for acute treatment, some for prevention, and some for both. Cefaly, Nerivio, gammaCore, and SAVI Dual combine acute and preventive indications. HeadaTerm 2 is cleared for episodic migraine prevention. Relivion MG is cleared for acute treatment only.

Review Prescription and Age Requirements

Cefaly and HeadaTerm 2 are available without a prescription in the United States for adults ages 18 and older. Nerivio is prescription-only for patients ages 8 and older. gammaCore and SAVI Dual are prescription-only for patients ages 12 and older.

Consider Device Placement

Placement differs substantially:

• Cefaly and HeadaTerm 2 are positioned on the forehead
• Nerivio is worn on the upper arm
• gammaCore is held against the side of the neck
• SAVI Dual is placed at the back of the head

Comfort, dexterity, skin sensitivity, and preferred treatment setting can influence how practical a device feels in daily use.

Compare Ownership and Refill Models

Cefaly and HeadaTerm 2 use a reusable, one-time purchase model with replaceable electrodes. Nerivio Infinity uses a rechargeable device with refill units that provide a fixed number of sessions. gammaCore uses prescription-based refill access. SAVI Dual uses a recurring monthly prescription model.

Account for Support Features

Support can extend beyond the stimulation session. Cefaly provides an optional app in supported regions, migraine tracking, health wearable integration, shareable reports, free coaching, and a directory of trained providers. Other products may include app control, connected diaries, manufacturer support, or clinician data-sharing features.

Why Cefaly Ranks First

For adults comparing at-home migraine prevention devices, Cefaly offers the most complete combination of access and product scope in this guide. It is the only prescription-free option listed here that combines an acute program and a preventive program in one reusable device.

Its main differentiators are practical rather than based on unsupported competitor evidence comparisons:

• Prescription-free access: Adults in the United States, Canada, and EU can purchase Cefaly without a prescription
• Two treatment programs: One device supports both acute migraine treatment and daily prevention
• Reusable ownership: The device is purchased once, with electrodes as the main ongoing product cost
• Cefaly-specific research: Its evidence base includes more than 20 years of research, more than 12 clinical trials, and 18 peer-reviewed publications
• Treatment support: App features, free coaching, HSA/FSA eligibility, and provider resources support ongoing use
• Broad adoption: More than 300,000 people have chosen Cefaly, and it is identified as the most frequently used migraine neuromodulation device among patients served by Veterans Health Administration providers

The mechanism of action is designed around e-TNS stimulation of trigeminal nerve branches through the forehead. The 20-minute Prevent program is used daily, while the 60-minute Acute program is used during an active migraine attack.

Cefaly does not cure migraine, and individual outcomes vary. Its first-place ranking reflects its combination of treatment scope, prescription-free access, reusable design, support services, and Cefaly-specific clinical evidence.

Frequently Asked Questions

How do at-home migraine prevention devices work?

Neuromodulation devices deliver electrical or magnetic stimulation to specific nerve pathways involved in migraine. Cefaly and HeadaTerm 2 stimulate trigeminal nerve branches through the forehead. Nerivio stimulates nerves in the upper arm through REN. gammaCore stimulates the vagus nerve through the neck. SAVI Dual uses magnetic pulses at the back of the head.

Which prevention devices are available without a prescription?

Cefaly and HeadaTerm 2 are available over the counter in the United States for adults ages 18 and older. Cefaly is the only prescription-free option in this guide with both acute and preventive programs.

How often are preventive devices used?

Treatment schedules vary. Cefaly uses a 20-minute Prevent session every day. Nerivio uses a 45-minute session every other day for prevention. gammaCore’s published preventive schedule uses two two-minute stimulations twice daily. SAVI Dual treatment is based on a personalized prescription plan. HeadaTerm 2 should be used according to its product labeling.

Can neuromodulation devices be used with migraine medication?

Neuromodulation devices are drug-free and do not create pharmacologic drug-drug interactions. However, each device has its own contraindications, warnings, and treatment instructions. Whether a device is used alone or as part of a broader migraine treatment plan depends on individual clinical circumstances.

Are at-home migraine devices safe?

FDA-cleared devices have product-specific safety information, contraindications, warnings, and precautions. They should not be treated as universally appropriate simply because they are non-invasive or drug-free. Cefaly’s cited studies report no serious device-related adverse effects, while reported minor effects include sleepiness, temporary post-session headache, forehead redness, and skin irritation. Safety information differs for other devices.

Which device is best for migraines with aura?

An aura diagnosis alone does not establish one universally best device. Cefaly, Nerivio, SAVI Dual, and Relivion MG include acute treatment of migraine with or without aura within their respective indications, although Relivion is not cleared for prevention. Age, prescription requirements, treatment purpose, placement, contraindications, and preferred access model remain important distinctions.